Our Mission
To improve the lives of patients affected by transthyretin amyloidoses through innovative therapeutic approaches.
Polyneuropathy and CNS Angiopathy
Oculopathy
Cardiomyopathy
Our News
What is happening in our universe.
BSIM Therapeutics is awarded a European Patent
BSIM attended the XVIIth International Symposium on Amyloidosis
BSIM at J.P. Morgan week
The 6th edition of The Meeting of Young Researchers in Computational Structural Biology (EJIBCE), sponsored by BSIM Therapeutics, took place at the Faculty of Sciences, University of Lisbon, on December 20, 2019.
By continuing to browse the site, you expressly agree that cookies will be stored on your computer to help measure statistics of visits and improve the quality of the contents offered.Learn more
